BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 17, 2000
View Archived Issues
Interaction regulating apoptosis could impact cancer therapy development
Read More
NF-kappaB implicated in mechanism underlying cachexia
Read More
Immtech begins DB-289 human trials for opportunistic infection
Read More
D-Pharm's neuroprotective drug candidate nears phase II
Read More
Anxiolytic-like effects described for nafadotride in animal model
Read More
NPS-1506: a summary of data up to early clinical trials in stroke patients
Read More
Preclinical and clinical experience with BMS-204352, a maxi-K channel opener, discussed at EFNS
Read More
Tempol exerts short- and long-term protective effects in stroke model
Read More
Effects of repeated doses of YF-476 on gastric pH examined in healthy volunteers
Read More
Successful treatment of breakthrough pain with intranasal morphine
Read More
Sonus refocuses development strategy towards drug delivery, blood substitutes
Read More
Clinical trials of new RSV therapeutic VP-14637 commence
Read More
FDA approves Novantrone for worsening forms of multiple sclerosis
Read More
Extended-release Lescol XL cleared by FDA for cholesterol reduction
Read More
Abbott researchers design novel water-soluble K+ channel openers
Read More
New agents for diabetes and related conditions emerge from joint research conducted at Japanese labs
Read More
Kyorin patents new AMPA receptor antagonists and their use
Read More
Novel antiinflammatory/immunomodulatory agents identified at Kowa
Read More
Aventis presents several related series of anorectic compounds
Read More
Preparation and use of new TK inhibitors as antiangiogenic agents
Read More
NIH grant awarded to Novasite to develop technology
Read More
Amgen to acquire Kinetix
Read More
Intellivax's nasal proteosome flu vaccine enters phase I
Read More
Enzyme replacement therapy for MPS VI proceeds to phase I/II
Read More
EGF receptor-related research collaboration with M.D. Anderson announced by Enchira
Read More
Cholera vaccine moves into phase IIb trials
Read More